FR2591894B1 - Immunotoxines a longue duree d'action in vivo comportant la chaine a de ricine modifiee sur ses motifs polysaccharidiques - Google Patents
Immunotoxines a longue duree d'action in vivo comportant la chaine a de ricine modifiee sur ses motifs polysaccharidiquesInfo
- Publication number
- FR2591894B1 FR2591894B1 FR8518981A FR8518981A FR2591894B1 FR 2591894 B1 FR2591894 B1 FR 2591894B1 FR 8518981 A FR8518981 A FR 8518981A FR 8518981 A FR8518981 A FR 8518981A FR 2591894 B1 FR2591894 B1 FR 2591894B1
- Authority
- FR
- France
- Prior art keywords
- immunotoxins
- polysaccharide
- lasting
- vivo
- patterns
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
- A61K47/6801—Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
- A61K47/6803—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
- A61K47/6811—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug being a protein or peptide, e.g. transferrin or bleomycin
- A61K47/6817—Toxins
- A61K47/6819—Plant toxins
- A61K47/6825—Ribosomal inhibitory proteins, i.e. RIP-I or RIP-II, e.g. Pap, gelonin or dianthin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
- A61K47/6801—Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
- A61K47/6803—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
- A61K47/6811—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug being a protein or peptide, e.g. transferrin or bleomycin
- A61K47/6817—Toxins
- A61K47/6819—Plant toxins
- A61K47/6825—Ribosomal inhibitory proteins, i.e. RIP-I or RIP-II, e.g. Pap, gelonin or dianthin
- A61K47/6827—Ricin A
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
- A61K47/6889—Conjugates wherein the antibody being the modifying agent and wherein the linker, binder or spacer confers particular properties to the conjugates, e.g. peptidic enzyme-labile linkers or acid-labile linkers, providing for an acid-labile immuno conjugate wherein the drug may be released from its antibody conjugated part in an acidic, e.g. tumoural or environment
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
- C07K1/1072—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
- C07K1/1072—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups
- C07K1/1077—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups by covalent attachment of residues other than amino acids or peptide residues, e.g. sugars, polyols, fatty acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Toxicology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Veterinary Medicine (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Botany (AREA)
- Genetics & Genomics (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Immunology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Analytical Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Priority Applications (19)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR8518981A FR2591894B1 (fr) | 1985-12-20 | 1985-12-20 | Immunotoxines a longue duree d'action in vivo comportant la chaine a de ricine modifiee sur ses motifs polysaccharidiques |
US06/941,990 US4911911A (en) | 1985-12-20 | 1986-12-15 | Ribosome-inactivating glycoproteins, modified by oxidation of their osidic units and formation of a schiff's base and in-vivo prolonged action immunotoxins containing such a glycoprotein |
IL80972A IL80972A (en) | 1985-12-20 | 1986-12-15 | Modified ribosome-inactivating glycoproteins,their preparation,immunotoxins containing them and pharmaceutical compositions containing such immunotoxins |
ES86402812T ES2020945B3 (es) | 1985-12-20 | 1986-12-16 | Glicoproteinas modificadas por oxidacion y formacion de bases de schiff, que inhiben los ribosomas, procedimiento de obtencion e inmunotoxinas que comprenden una glicoproteina como esta. |
AT86402812T ATE59049T1 (de) | 1985-12-20 | 1986-12-16 | Die ribosome inhibierende, mittels oxidation und bildung von schiffbasen modifizierte glukoproteine, verfahren zur herstellung derselben und ein solches glukoprotein enthaltende immunotoxine. |
EP86402812A EP0234151B1 (fr) | 1985-12-20 | 1986-12-16 | Glycoprotéines modifiées par oxydation et formation de base de Schiff, inhibant les ribosomes, procédé d'obtention et immunotoxines comprenant une telle glycoprotéine |
DE8686402812T DE3676187D1 (de) | 1985-12-20 | 1986-12-16 | Die ribosome inhibierende, mittels oxidation und bildung von schiffbasen modifizierte glukoproteine, verfahren zur herstellung derselben und ein solches glukoprotein enthaltende immunotoxine. |
PT83946A PT83946B (pt) | 1985-12-20 | 1986-12-17 | Processo para a obtencao de glicoproteinas inibidoras dos ribosomas, modificadas por oxidacao das funcoes osidicas e formacao de uma base de schiff |
CA000525646A CA1276108C (fr) | 1985-12-20 | 1986-12-17 | Procede de modification des glycoproteines inactivant les ribosomes par oxydation des groupements oside et formation d'une base de schiff |
AU66630/86A AU602320B2 (en) | 1985-12-20 | 1986-12-17 | Ribosome inactivating glycoproteins, modified by oxidation of their osidic units and formation of a schiff's base and in-vivo prolonged-action immunotoxins containing such a glycoprotein |
NZ218705A NZ218705A (en) | 1985-12-20 | 1986-12-18 | Glycoproteins with ribosome-inhibiting properties and immunotoxins |
IE330586A IE59649B1 (en) | 1985-12-20 | 1986-12-18 | Ribosome-inactivating glycoproteins, modified by oxidation of their osidic units and formation of a schiff's base and invivo prolonged-action immunotoxins containing such a glycoprotein |
DK611886A DK611886A (da) | 1985-12-20 | 1986-12-18 | Riboson-inaktiverende glycoproteiner og immunotoksiner med forlaengetvirkning in vivo, der indeholder et saadant glycoprotein |
ZA869572A ZA869572B (en) | 1985-12-20 | 1986-12-19 | Ribosome-inactivating glycoproteins,modified by oxidation of their osidic units and formation of a schiff's base and in-vivo prolonged-action immunotoxins containing such a glycoprotein |
AR86306243A AR242958A1 (es) | 1985-12-20 | 1986-12-19 | Un procedimiento para la obtencion de un gpir modificada, y procedimiento para obtener una inmunotoxina utilizando dicho gpir modificada. |
JP61302889A JPH0742316B2 (ja) | 1985-12-20 | 1986-12-20 | オシド単位の酸化およびシツフ塩基の形成により変性されたリボソ−ム不活性化糖タンパク、およびこの糖タンパクを含む生体内持続性免疫毒素 |
KR1019860011019A KR950007215B1 (ko) | 1985-12-20 | 1986-12-20 | 오시딕 단위를 산화시키고 쉬프염기를 형성하여 리보솜을 비활성화시키는 당단백질을 변형시키는 방법 |
US07/404,052 US5104976A (en) | 1985-12-20 | 1989-09-08 | Ribosome-inactivating glycoproteins, modified by oxidation of their osidic units and formation of a schiff's base and in-vivo prolonged action immunotoxins containing such a glycoprotein |
GR91400316T GR3001597T3 (en) | 1985-12-20 | 1991-03-12 | Glycoproteins modified by oxidation and formation of schiff bases, inhibiting ribosomes, process for obtaining the same, and immunotoxines containing such glycoprotein |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR8518981A FR2591894B1 (fr) | 1985-12-20 | 1985-12-20 | Immunotoxines a longue duree d'action in vivo comportant la chaine a de ricine modifiee sur ses motifs polysaccharidiques |
Publications (2)
Publication Number | Publication Date |
---|---|
FR2591894A1 FR2591894A1 (fr) | 1987-06-26 |
FR2591894B1 true FR2591894B1 (fr) | 1988-04-01 |
Family
ID=9326038
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR8518981A Expired FR2591894B1 (fr) | 1985-12-20 | 1985-12-20 | Immunotoxines a longue duree d'action in vivo comportant la chaine a de ricine modifiee sur ses motifs polysaccharidiques |
Country Status (2)
Country | Link |
---|---|
FR (1) | FR2591894B1 (fr) |
ZA (1) | ZA869572B (fr) |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL47372A (en) * | 1975-05-27 | 1979-10-31 | Yeda Res & Dev | Fab'dimers bound to daunomycin or adriamycin,their preparation and pharmaceutical compositions containing same |
JPS5843926A (ja) * | 1981-09-08 | 1983-03-14 | Suntory Ltd | 選択性制癌剤 |
CA1203164A (fr) * | 1982-03-09 | 1986-04-15 | Thomas J. Mckearn | Conjugats d'anticorps |
-
1985
- 1985-12-20 FR FR8518981A patent/FR2591894B1/fr not_active Expired
-
1986
- 1986-12-19 ZA ZA869572A patent/ZA869572B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
FR2591894A1 (fr) | 1987-06-26 |
ZA869572B (en) | 1987-08-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO307835B1 (no) | Ikke-farmasøytisk polysakkaridkonjugat | |
DE68927097D1 (de) | Differentieller refraktometer | |
FI905579A0 (fi) | Modem med flera arbetssaett. | |
DE68928739D1 (de) | Detecteur d'humidite | |
MX164779B (es) | Mejoras a ductos de poliepoxido-polioxalquilenpoliamina glicidol modificados | |
DK0734212T3 (da) | Kontaktflade med naturligt aftryk | |
DE68927610D1 (de) | Antikörper-Arzneimittel Konjugale | |
DK186190D0 (da) | Samlbaandet gmsk-modem | |
EP0383868A4 (en) | 1,3-unsymmetrical straight chain alkyl-substituted 8-phenylxanthines | |
MX164394B (es) | Llavero | |
FR2591895B1 (fr) | Immunotoxines a longue duree d'action in vivo comportant la chaine a de ricine modifiee sur ses motifs polysaccharidiques | |
MX164816B (es) | Composicion y metodo para producir 1,3,5-trinitro-2,4,6-tripicrilbenceno | |
IT8822249A0 (it) | Perfezionamenti apportati a borse e prodotti similari. | |
FR2591894B1 (fr) | Immunotoxines a longue duree d'action in vivo comportant la chaine a de ricine modifiee sur ses motifs polysaccharidiques | |
PT91615A (pt) | Ensemble d'allaitement | |
IT1240753B (it) | Albero a camme e metodo per produrlo. | |
KR900700425A (ko) | 2,3-디플루오로페놀 유도체 | |
FR2646221B1 (fr) | Joint d'etancheite, dispositif le comportant et application a une turbomachine | |
KR920003449B1 (en) | Tripple rail logic gate | |
IT1183667B (it) | Catena ad aghi e a griffa | |
ZA876594B (en) | Triblock polymer and synthesis technique | |
FR2628333B1 (fr) | Engin de glisse sur neige | |
FR2567164B1 (fr) | Machine de detorsion et d'ouverture des tricots. | |
IT1245851B (it) | 13-desosso-4'-desossi-4'-iodoantracicline | |
FR2579710B1 (fr) | Chaine constituee de maillons munis chacun d'un couple de colliers |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ST | Notification of lapse |